CTSS and melanoma: Pretreatment of melanoma cells with E64d, a protease inhibitor targeting a limited number of protelytic enzymes including cathepsins (see Methods) or specific inhibitor of cathepsins (CI3), followed by extensive washing before conjugation with CTL, significantly increased cytotoxicity (Fig. 7d,e).